Abbonarsi

Utility of ED triage tools in predicting the need for intensive respiratory or vasopressor support in adult patients with COVID-19 - 19/03/24

Doi : 10.1016/j.ajem.2024.01.034 
Anandhi Deva, MD a, Ronit Juthani, MBBS b, , Ezhil Kugan, MD a, N. Balamurugan, MD a, Manu Ayyan, MD a
a Department of Emergency Medicine & Trauma, JIPMER, Puducherry, India 
b Department of Medicine, Saint Vincent Hospital, Worcester, MA, United States 

Corresponding author at: 26 Portland Street, #208, Worcester, MA 01608, United States.26 Portland Street, #208WorcesterMA01608United States

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Serum and radiological parameters used to predict prognosis in COVID patients are not feasible in the Emergency Department. Due to its damaging effect on multiple organs and lungs, scores used to assess multiorgan damage and pneumonia such as Pandemic Medical Early Warning Score (PMEWS), National Early Warning Score 2 (NEWS2), WHO score, quick Sequential Organ Failure Assessment (qSOFA), and DS-CRB 65 can be used to triage patients in the Emergency Department. They can be used to predict patients with the highest risk of seven-day mortality and need for intensive respiratory or vasopressor support (IRVS).

Purpose

The primary purpose was to find the score with the highest AUC in predicting IRVS and mortality at seven days. Additional objective was to find out any independent factors associated with IRVS and mortality.

Methods

The data of adult patients who presented to the Emergency Department (ED) between April 1, 2021 and June 30, 2021 were collected. The WHO score, CRB-65, DS-CRB 65, PMEWS, NEWS2, and qSOFA score were calculated for all patients. Statistical analysis was done and an ROC curve was calculated for all the tools for mortality and need for IRVS at seven days.

Findings

677 patients presented to the Emergency Department with COVID-19 during the period above. Presence of Diabetes Mellitus (p = 0.001), Hypertension (p = 0.001), and chronic kidney disease(CKD) (p = 0.04) was significantly associated with need for IRVS. Age, duration of symptoms, pulse rate, respiratory rate, room air saturation, mental status at admission, and time to IRVS need were identified as independent predictors of in-hospital mortality. The longer the time to IRVS need from ED arrival, the higher the likelihood of mortality. PMEWS (0.830) had the highest AUC, followed by NEWS2 (0.805). A PMEWS cut-off of 6.5 was 74.2% sensitive and 78.3% specific in predicting the need for IRVS. ROC analysis to predict 7-day mortality showed that PMEWS had an AUC of 0.802 (0.766–0.839). QSOFA performed poorly in predicting IRVS (AUC 0.645) and 7-day mortality (AUC 0.677).

Conclusion

PMEWS may be used for triaging patients presenting to the Emergency Department with COVID-19 and accurately predicts the need for IRVS and seven day mortality.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

PMEWS has good sensitivity and specificity for predicting the need for intensive respiratory and vasopressor as well as mortality in the next seven days for COVID-19.
Other tools which can be used and that offer comparable ratios include NEWS2, DS-CRB 65, and WHO score.
The mortality increases with the increase in the number of days post admission before ventilator use.
The predictivity of triaging tools can vary not only with the population tested but also with the variant of COVID-19.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Triage, COVID, MEWS, NEWS, Ventilation


Mappa


© 2024  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 78

P. 151-156 - Aprile 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Predictors of cardiac arrest in severe accidental hypothermia
  • Paweł Podsiadło, Tomáš Brožek, Martin Balik, Ewelina Nowak, Konrad Mendrala, Hubert Hymczak, Wojciech Dąbrowski, Bartosz Miazgowski, Aleksander Rutkiewicz, Marian Burysz, Anna Witt-Majchrzak, Tomasz Jędrzejczak, Rafał Podsiadło, Tomasz Darocha, Hypothermia Study Group, Kacper Reszka, Guillaume Debaty, Nicolas Segond, Michał Dudek, Radosław Litwinowicz, Stanisław Górski, Sylweriusz Kosiński, Roch Pakuła
| Articolo seguente Articolo seguente
  • Combined modified Valsalva maneuver with adenosine supraventricular tachycardia: A comparative study
  • Lifeng Xiao, Xiaomin Ou, Wanshang Liu, Xiaorong Lin, Lin Peng, Shuyi Qiu, Qishuo Zhang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.